Reference: Zar HJ, Bont LJ, Manzoni P, et al. Clesrovimab in infants and children at increased risk for severe RSV disease. N Engl J Med. 2025;393(13):1343-1345. This interim analysis from the SMART trial represents a...
Tag - Respiratory Syncytial Virus (RSV)
